We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026
20 Aug 2026 - 22 Aug 2026

Gene Found to Be Associated with SIDS

By HospiMedica staff writers
Posted on 05 Feb 2003
Researchers have discovered a positive association between sudden infant death syndrome (SIDS) and the 5-HTT gene, which they say may lead to the ability to identify infants at risk for SIDS. More...
Their discovery was reported in the January 17, 2003 online edition of the American Journal of Medical Genetics.

The study was prompted by previous observations of decreased serotonergic receptor binding in SIDS cases. The 5-HTT gene regulates membrane uptake of serotonin and was therefore considered a likely candidate for SIDS studies. The investigators, from Rush-Presbyterian-St. Luke's Medical Center (Chicago, IL, USA), collected DNA samples from 87 US SIDS cases and from two sets of control subjects. The first set was screened for family history of SIDS and then matched to the SIDS cases for ethnicity and gender. The second set of controls included 33 random DNA samples used to determine population genotype frequencies. For each DNA sample, the 5-HTTLPR polymorphism was genotyped.
The results showed a significant positive association between SIDS and the L/L genotype and between SIDS and the 5-HTT L allele, and a negative association between SIDS and the S/S genetoype. SIDS cases were more likely than controls to have the long allele in the Japanese, Caucasian, and African-American study samples.

"If a larger data set reflects observations similar to those in this report,” the authors conclude, "the serotonergic system will represent a key area for further investigation into the casual basis for SIDS, with the goal of identifying genetic risk factors that will aid in recognizing at-risk individuals who require specialized intervention strategies and in counseling families as to the risk of recurrence.”




Related Links:
Rush-Presbyterian-St. Luke's Medical Center

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Gas Analyzer
GE SAM
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.